Evripidis Gavathiotis, PhD is an assistant professor in the Departments of Biochemistry and Medicine of the Albert Einstein College of Medicine. Dr. Gavathoitis’ PhD training was in the areas of biological and biophysical chemistry at the University of Nottingham, followed by postdoctoral training in chemical and structural biology at the Rockefeller Univeristy and Harvard Medical School. Dr. Gavathiotis’ group is committed to define and chemically manipulate the precise protein-protein interactions that modulate cell death and survival signaling pathways and contribute to disease such as cancer and neurodegeneration. His group has used innovative approaches to establish novel pharmacological targets and chemical probes for apoptosis and chaperone-mediated autophagy signaling.

Dr. Gavathiotis has published articles in peer-reviewed journals in the areas of chemical biology, structural biology, medicinal chemistry and drug discovery, and he is an inventor of several patents. Dr. Gavathiotis is currently the recipient of a Kimmel Scholar Award, the Gabrielle’s Angels Fellow Award, the Alexandrine and Alexander Sinsheimer Award and the NIH Pathway to Independence Award.